Mark Velleca is the founder of G1 Therapeutics. G1 Therapeutics has raised $13M in total funding. Latest round: Series A. Based in Research Triangle Park, NC.
Dr. Mark Velleca is a biotech executive who served as the Chief Executive Officer (CEO) of G1 Therapeutics from 2014 until stepping down in 2015 after the company's Series A round. He joined G1 Therapeutics following its Series A financing and led the company through its $33 million Series B round in February 2015.
Full founder directory · Investor directory · Company funding database · Fundraising library